Health Care Deal News, April 7, 2014 - March 2014 Came in Like a Lion, and Some Would say it Went out Like a Lion, The Beginning and End of Each Month Brings a Flurry of Long-Term Care Transactions

 

Brought to you by www.DealSearchOnline.com
 

April 7, 2014 Issue:

 

Recent Health Care M&A Deals

Biotechnology

 

 

Acquirer

Target

Price

Anavex Life Sciences Corp.

Rights to AF710B

N/A

Baxter International Inc.

Chatham Therapeutics

$70 million

Verde Media Group Inc.

Butazyme

$5 million

Hospitals

 

 

Alecto Healthcare Services

Fairmont General Hospital

N/A

Laboratories, MRI and Dialysis

 

 

Acquirer

Target

Price

Blood Centers of America, Inc.

GSABC Cooperative Corp.

Merger

 

Technology Deal of the Week
Ever on the acquisition path, Actavis plc (NYSE: ACT) agreed to pay $100 million for Silom Medical Company, a privately held generic pharmaceutical company focused on developing and marketing therapies in Thailand. Actavis already had about a dozen products in the Thai market, but this acquisition makes it the fifth-largest generic drug marketer in Thailand, with leading positions in ophthalmic and respiratory therapeutic categories, and a strong cardiovascular franchise.......Want to read more news? Click here for a free trial to The Health Care M&A Information Source and download the current issue today.

 

Charted Territory
March 2014 came in like a lion, and some would say it went out like a lion, too. As for deal-making in the healthcare industry, March just gamboled along. Our preliminary data shows 74 transactions announced last month, for a combined total of approximately $4.2 billion. As usual, the Long-Term Care sector was the most active, with 25 deals announced, followed by Pharmaceuticals, with 12 deals.     
 

Top 10 Health Care M&A Transactions in March 2014

Acquirer

Target

Price

NorthStar Realty Finance

80 senior care facilities

$1.05 billion

Sterigenics International LLC

Nordion Inc.

$727 million

Horizon Pharma Inc.

Vidara Therapeutics International

$660 million

Kayne Anderson Real Estate Advisors

Conservatory Senior Living portfolio

$290 million

Concordia Healthcare Corp.

Donnatal®

$265.3 million

Vectura Group plc

Activaero GmbH

$181 million

Charles River Laboratories

CRO division of Galapagos NV

$179 million

ICON plc

Aptiv Solutions

$143.5 million

AEW Capital Management

3 Balfour Senior Living communities

$103.8 million

Kythera Biopharmaceuticals

Rights to ATX-101

$84 million

Source: The Health Care M&A News, April 2014

Want to read more news? Click here for a free trial to The Health Care M&A Information Source and download the current issue today

 

Services Deal of the Week
The beginning and end of each month brings a flurry of Long-Term Care transactions, and last week was no exception. Kayne Anderson Real Estate Advisors, the real estate arm of Kayne Anderson Capital Advisors LP, paid $290 million for the Conservatory Senior Living portfolio. The portfolio consists of five independent living communities across Texas, whose average occupancy rate was well below 90%. Discovery Senior Living will manage the portfolio for Kayne Anderson.........Want to read more news? Click here for a free trial to The Health Care M&A Information Source and download the current issue today.

 

In the Pipeline
In case you weren’t paying attention, Neurovance announced it had pulled in another $6.3 million beyond its earlier Series A, which it will use to continue developing a promising non-stimulant treatment for attention deficit hyperactivity disorder. Lead investor Novartis Venture Fund provided the follow-on financing, augmenting a $7 million A round closed in 2010 and joining previous backers Venture Investors, H&Q Healthcare Investors and H&Q Life Sciences Investors, GBS Venture Partners, State of Wisconsin Investment Board and Timothy J. Barberich........Want to read more news? Click here for a free trial to The Health Care M&A Information Source and download the current issue today.

 

Sharpen strategies at the leading medtech event of the year!

Medical Technology is at the height of the innovation landscape, and the leading medtech innovators and investors are convening at the MedTech Investing Conference taking place on May 21, 2014 in Minneapolis, Minnesota.
Recognized as the “must attend” event by industry professionals, this conference brings together the best of the best, facilitating both investment and commercialization strategizing between key players.
Are you an innovator looking to bring your technology to market? Or an investor hoping to discover the latest and greatest advancements? Don’t miss opportunities for high caliber strategic partnership building at this prestigious event!
For more details visit:
www.medtechconference.com

 

NEW - The Health Care Services Acquisition Report, 20th Edition - Order Today!

Deals have been made. The 2014 Health Care Services Acquisition Report contains private deals in this market that are frequently too small to make into financial press. Order by April 30th and get our Senior Care M&A Market Review and 2014 Outlook webcast for FREE ($147 value). Now that’s a deal! Go to http://www.levinassociates.com/landing/har20order or call 800-248-1668 to preorder today.

 

 

Around the Web in Health Care M&A...Click here to see more

 
Webcast Calendar...Click here to see more

 

Upcoming Conference Partnerships... Click here to see more